

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 6.88077418 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.33247358 |
| 3 | response to peptidoglycan (GO:0032494) | 5.93917219 |
| 4 | urate metabolic process (GO:0046415) | 5.90081148 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.82907214 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.82907214 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.82907214 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.82907214 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.82907214 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.82907214 |
| 11 | drug transport (GO:0015893) | 5.82349085 |
| 12 | detection of other organism (GO:0098543) | 5.75478440 |
| 13 | detection of bacterium (GO:0016045) | 5.61161254 |
| 14 | drug catabolic process (GO:0042737) | 5.55177199 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.47898082 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 5.37725830 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.37725830 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.35326079 |
| 19 | negative regulation of cell killing (GO:0031342) | 5.35326079 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 5.25620959 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.25620959 |
| 22 | lysine catabolic process (GO:0006554) | 5.19632975 |
| 23 | lysine metabolic process (GO:0006553) | 5.19632975 |
| 24 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.84169749 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.83641779 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 4.82949624 |
| 27 | organic cation transport (GO:0015695) | 4.80503494 |
| 28 | neutrophil activation (GO:0042119) | 4.80396823 |
| 29 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.74878115 |
| 30 | detection of external biotic stimulus (GO:0098581) | 4.74110449 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.73700248 |
| 32 | cysteine metabolic process (GO:0006534) | 4.72127807 |
| 33 | leukocyte aggregation (GO:0070486) | 4.64809616 |
| 34 | exogenous drug catabolic process (GO:0042738) | 4.61181417 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 4.53423881 |
| 36 | phosphate ion transport (GO:0006817) | 4.50491393 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.50105834 |
| 38 | glyoxylate metabolic process (GO:0046487) | 4.45612914 |
| 39 | granulocyte activation (GO:0036230) | 4.42508631 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 4.40642139 |
| 41 | cellular extravasation (GO:0045123) | 4.40160573 |
| 42 | respiratory burst (GO:0045730) | 4.38607416 |
| 43 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.35600213 |
| 44 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.35600213 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 4.35440811 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34337279 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 4.31939487 |
| 48 | flavonoid metabolic process (GO:0009812) | 4.22524735 |
| 49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.20932075 |
| 50 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.18989059 |
| 51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17962345 |
| 52 | response to host immune response (GO:0052572) | 4.17962345 |
| 53 | intestinal absorption (GO:0050892) | 4.17614576 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14586547 |
| 55 | homocysteine metabolic process (GO:0050667) | 4.13177311 |
| 56 | detection of biotic stimulus (GO:0009595) | 4.11302931 |
| 57 | short-chain fatty acid metabolic process (GO:0046459) | 4.10169308 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 3.95917144 |
| 59 | fructose metabolic process (GO:0006000) | 3.94376616 |
| 60 | response to host (GO:0075136) | 3.94217088 |
| 61 | response to host defenses (GO:0052200) | 3.94217088 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.94217088 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.93368344 |
| 64 | ketone body metabolic process (GO:1902224) | 3.90748177 |
| 65 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.86784616 |
| 66 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.84571131 |
| 67 | ATP synthesis coupled proton transport (GO:0015986) | 3.84571131 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.82819260 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 3.82583742 |
| 70 | response to mercury ion (GO:0046689) | 3.78353146 |
| 71 | neutrophil mediated immunity (GO:0002446) | 3.78145064 |
| 72 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.75646070 |
| 73 | phosphate ion transmembrane transport (GO:0035435) | 3.74033076 |
| 74 | indole-containing compound catabolic process (GO:0042436) | 3.72593087 |
| 75 | indolalkylamine catabolic process (GO:0046218) | 3.72593087 |
| 76 | tryptophan catabolic process (GO:0006569) | 3.72593087 |
| 77 | excretion (GO:0007588) | 3.71820217 |
| 78 | sulfur amino acid catabolic process (GO:0000098) | 3.71815327 |
| 79 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.71460093 |
| 80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.68553797 |
| 81 | glutathione biosynthetic process (GO:0006750) | 3.68488115 |
| 82 | quaternary ammonium group transport (GO:0015697) | 3.64354435 |
| 83 | proline metabolic process (GO:0006560) | 3.63737481 |
| 84 | respiratory electron transport chain (GO:0022904) | 3.63149767 |
| 85 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62847626 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.62728118 |
| 87 | vitamin D metabolic process (GO:0042359) | 3.62529895 |
| 88 | tryptophan metabolic process (GO:0006568) | 3.58644415 |
| 89 | modified amino acid transport (GO:0072337) | 3.57596398 |
| 90 | electron transport chain (GO:0022900) | 3.57349910 |
| 91 | renal absorption (GO:0070293) | 3.56751777 |
| 92 | intestinal cholesterol absorption (GO:0030299) | 3.54959203 |
| 93 | microglial cell activation (GO:0001774) | 3.54695767 |
| 94 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.54074313 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 3.53147111 |
| 96 | fatty acid beta-oxidation (GO:0006635) | 3.52769365 |
| 97 | leukocyte degranulation (GO:0043299) | 3.52134755 |
| 98 | cellular modified amino acid catabolic process (GO:0042219) | 3.51547486 |
| 99 | tricarboxylic acid metabolic process (GO:0072350) | 3.51532001 |
| 100 | positive regulation of mast cell activation (GO:0033005) | 3.47378398 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.44799046 |
| 102 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44746548 |
| 103 | macrophage activation (GO:0042116) | 3.44215382 |
| 104 | amino-acid betaine metabolic process (GO:0006577) | 3.43540640 |
| 105 | drug metabolic process (GO:0017144) | 3.43472134 |
| 106 | aromatic amino acid family metabolic process (GO:0009072) | 3.40730624 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 3.38929258 |
| 108 | NADH metabolic process (GO:0006734) | 3.38674237 |
| 109 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.37251454 |
| 110 | glutathione derivative biosynthetic process (GO:1901687) | 3.33639749 |
| 111 | glutathione derivative metabolic process (GO:1901685) | 3.33639749 |
| 112 | regulation of mast cell activation (GO:0033003) | 3.32827512 |
| 113 | glutathione metabolic process (GO:0006749) | 3.29982563 |
| 114 | sulfur compound transport (GO:0072348) | 3.28644853 |
| 115 | glycoside metabolic process (GO:0016137) | 3.27746157 |
| 116 | uronic acid metabolic process (GO:0006063) | 3.27466710 |
| 117 | glucuronate metabolic process (GO:0019585) | 3.27466710 |
| 118 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.26094667 |
| 119 | fatty acid oxidation (GO:0019395) | 3.26085895 |
| 120 | serine family amino acid catabolic process (GO:0009071) | 3.25182564 |
| 121 | peptide catabolic process (GO:0043171) | 3.25018467 |
| 122 | lipid oxidation (GO:0034440) | 3.19918627 |
| 123 | type I interferon signaling pathway (GO:0060337) | 3.18027899 |
| 124 | cellular response to type I interferon (GO:0071357) | 3.18027899 |
| 125 | fatty acid catabolic process (GO:0009062) | 3.17779456 |
| 126 | kynurenine metabolic process (GO:0070189) | 3.17760824 |
| 127 | negative regulation of interleukin-6 production (GO:0032715) | 3.16924735 |
| 128 | B cell mediated immunity (GO:0019724) | 3.16729286 |
| 129 | response to muramyl dipeptide (GO:0032495) | 3.15797148 |
| 130 | response to type I interferon (GO:0034340) | 3.13867850 |
| 131 | neutrophil chemotaxis (GO:0030593) | 3.13297482 |
| 132 | vitamin transport (GO:0051180) | 3.12966585 |
| 133 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12231648 |
| 134 | transepithelial transport (GO:0070633) | 3.11964845 |
| 135 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11953818 |
| 136 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.11932065 |
| 137 | regulation of gamma-delta T cell activation (GO:0046643) | 3.11210059 |
| 138 | peptide biosynthetic process (GO:0043043) | 3.10403043 |
| 139 | germinal center formation (GO:0002467) | 3.10106777 |
| 140 | cellular glucuronidation (GO:0052695) | 3.09499200 |
| 141 | regulation of regulated secretory pathway (GO:1903305) | 3.09494639 |
| 142 | response to interleukin-15 (GO:0070672) | 3.08958761 |
| 143 | positive regulation of mast cell degranulation (GO:0043306) | 3.08127683 |
| 144 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.08127683 |
| 145 | regulation of cholesterol homeostasis (GO:2000188) | 3.08017283 |
| 146 | myeloid leukocyte mediated immunity (GO:0002444) | 3.07024697 |
| 147 | carnitine metabolic process (GO:0009437) | 3.06631685 |
| 148 | angiotensin maturation (GO:0002003) | 3.05047549 |
| 149 | neutrophil migration (GO:1990266) | 3.04983233 |
| 150 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02548775 |
| 151 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00480696 |
| 152 | branched-chain amino acid metabolic process (GO:0009081) | 3.00344992 |
| 153 | aldehyde catabolic process (GO:0046185) | 2.99485322 |
| 154 | monocarboxylic acid catabolic process (GO:0072329) | 2.96778829 |
| 155 | sulfate transmembrane transport (GO:1902358) | 2.96206613 |
| 156 | defense response to protozoan (GO:0042832) | 2.94907967 |
| 157 | negative regulation of phagocytosis (GO:0050765) | 2.94048487 |
| 158 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.93814145 |
| 159 | benzene-containing compound metabolic process (GO:0042537) | 2.93670793 |
| 160 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93605898 |
| 161 | superoxide anion generation (GO:0042554) | 2.93274984 |
| 162 | trivalent inorganic anion homeostasis (GO:0072506) | 2.91193015 |
| 163 | phosphate ion homeostasis (GO:0055062) | 2.91193015 |
| 164 | indolalkylamine metabolic process (GO:0006586) | 2.90990394 |
| 165 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.90922331 |
| 166 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.90858073 |
| 167 | myeloid leukocyte activation (GO:0002274) | 2.90599629 |
| 168 | cellular amino acid catabolic process (GO:0009063) | 2.90513213 |
| 169 | bile acid and bile salt transport (GO:0015721) | 2.88635623 |
| 170 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.88484240 |
| 171 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.88432999 |
| 172 | neurotransmitter biosynthetic process (GO:0042136) | 2.88144019 |
| 173 | regulation of bile acid biosynthetic process (GO:0070857) | 2.87416548 |
| 174 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.86516296 |
| 175 | serine family amino acid metabolic process (GO:0009069) | 2.85977042 |
| 176 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.85876948 |
| 177 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.85876948 |
| 178 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.85876948 |
| 179 | alkaloid metabolic process (GO:0009820) | 2.85719603 |
| 180 | response to phenylpropanoid (GO:0080184) | 2.84522580 |
| 181 | glutamate metabolic process (GO:0006536) | 2.83720055 |
| 182 | dendritic cell migration (GO:0036336) | 2.83107026 |
| 183 | endocrine pancreas development (GO:0031018) | 2.82689185 |
| 184 | acetyl-CoA metabolic process (GO:0006084) | 2.82138201 |
| 185 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.80337949 |
| 186 | positive regulation of regulated secretory pathway (GO:1903307) | 2.79141155 |
| 187 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.77837756 |
| 188 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.76744598 |
| 189 | regulation of T cell tolerance induction (GO:0002664) | 2.76132502 |
| 190 | cellular response to interleukin-15 (GO:0071350) | 2.75415427 |
| 191 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73883008 |
| 192 | negative regulation of interleukin-8 production (GO:0032717) | 2.73304977 |
| 193 | response to fungus (GO:0009620) | 2.70937733 |
| 194 | negative regulation of innate immune response (GO:0045824) | 2.69259767 |
| 195 | dendritic cell chemotaxis (GO:0002407) | 2.68890051 |
| 196 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.68863951 |
| 197 | positive regulation of interleukin-17 production (GO:0032740) | 2.68216960 |
| 198 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.68195290 |
| 199 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.68195290 |
| 200 | regulation of tolerance induction (GO:0002643) | 2.68061947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.50668768 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.99155428 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.50073025 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.22074344 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.07530205 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.94986238 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.82880758 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76371401 |
| 9 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.74122895 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.71909526 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.55099855 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41156162 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02132802 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.94874093 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.94814505 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89033115 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86750092 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.77273313 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.76255789 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.66948687 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.66826407 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.64822457 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.64067588 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.52461354 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.46414961 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.46109822 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.44753787 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41421769 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40785149 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.37160379 |
| 31 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.35978548 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25783922 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.24564392 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.23362201 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.22358403 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21335111 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.18868794 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17402064 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16851450 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12191399 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 2.09548729 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09406134 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07429218 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.04787456 |
| 45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01854568 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95724698 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.92992700 |
| 48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.84745517 |
| 49 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.82979246 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82110810 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81496052 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79721014 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76798553 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75827791 |
| 55 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.74827340 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.71702284 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70906384 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69371250 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69128655 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66672831 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65195968 |
| 62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65059155 |
| 63 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.64894102 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.64811457 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62251336 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61911045 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60560243 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60408408 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60364350 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.58842095 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57755739 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.57239995 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.55668935 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55494374 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54830759 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54512124 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52530844 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51278961 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51010759 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50855907 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50599819 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48795265 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46369352 |
| 84 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44746103 |
| 85 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41911974 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41684589 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41211865 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40460912 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40418214 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39920546 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39718453 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39691094 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39220228 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38809734 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38182122 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35541004 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35300559 |
| 98 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34503257 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29847655 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29338105 |
| 101 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.28463983 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26618968 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24792912 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24288122 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20333935 |
| 106 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18183052 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17667858 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17059847 |
| 109 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16719368 |
| 110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13437532 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13272080 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12467581 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.12244979 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11940521 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11178602 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09022223 |
| 117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08848758 |
| 118 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07606638 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06295108 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06214963 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06053464 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05310499 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.04308494 |
| 124 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04207537 |
| 125 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.04129632 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03860286 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03541037 |
| 128 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02536875 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02322508 |
| 130 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02210902 |
| 131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00726740 |
| 132 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00355168 |
| 133 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00212758 |
| 134 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.99116388 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98372257 |
| 136 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98028021 |
| 137 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97460953 |
| 138 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96282480 |
| 139 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95656362 |
| 140 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95656362 |
| 141 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94395500 |
| 142 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93843600 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93298263 |
| 144 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92502069 |
| 145 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91546389 |
| 146 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.91431328 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91295990 |
| 148 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91012327 |
| 149 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90867557 |
| 150 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90459246 |
| 151 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89824298 |
| 152 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89285929 |
| 153 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89045740 |
| 154 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87204474 |
| 155 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81735214 |
| 156 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81726005 |
| 157 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81294441 |
| 158 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80878533 |
| 159 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80421485 |
| 160 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.79943720 |
| 161 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.79753013 |
| 162 | AR_20517297_ChIP-Seq_VCAP_Human | 0.78811754 |
| 163 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77837594 |
| 164 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77468990 |
| 165 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.77155596 |
| 166 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.77103166 |
| 167 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77068319 |
| 168 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.76105983 |
| 169 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76043825 |
| 170 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75688317 |
| 171 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75677429 |
| 172 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75581773 |
| 173 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.73808544 |
| 174 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.73655515 |
| 175 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.72311256 |
| 176 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.72141805 |
| 177 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.72070756 |
| 178 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.71601938 |
| 179 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.71461008 |
| 180 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.71406568 |
| 181 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71254264 |
| 182 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.71202650 |
| 183 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.70954497 |
| 184 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70182558 |
| 185 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70091919 |
| 186 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67607495 |
| 187 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67607495 |
| 188 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.67186283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.66504541 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.48874131 |
| 3 | MP0004043_abnormal_pH_regulation | 4.69153748 |
| 4 | MP0003724_increased_susceptibility_to | 4.57594309 |
| 5 | MP0003436_decreased_susceptibility_to | 4.18894297 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.68962768 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.68950132 |
| 8 | MP0003303_peritoneal_inflammation | 3.57159545 |
| 9 | MP0005332_abnormal_amino_acid | 3.43092090 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.41040992 |
| 11 | MP0002419_abnormal_innate_immunity | 3.20575327 |
| 12 | MP0005365_abnormal_bile_salt | 3.18004356 |
| 13 | MP0009785_altered_susceptibility_to | 3.12309430 |
| 14 | MP0003195_calcinosis | 3.12077340 |
| 15 | MP0009643_abnormal_urine_homeostasis | 3.01602624 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.96628244 |
| 17 | MP0006082_CNS_inflammation | 2.92896724 |
| 18 | MP0003252_abnormal_bile_duct | 2.82343036 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.80719122 |
| 20 | MP0005025_abnormal_response_to | 2.77453144 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.76025763 |
| 22 | MP0003283_abnormal_digestive_organ | 2.75611887 |
| 23 | MP0008260_abnormal_autophagy | 2.60117615 |
| 24 | MP0005387_immune_system_phenotype | 2.56130824 |
| 25 | MP0001790_abnormal_immune_system | 2.56130824 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.55575628 |
| 27 | MP0001765_abnormal_ion_homeostasis | 2.54669550 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 2.49741994 |
| 29 | MP0000685_abnormal_immune_system | 2.45952638 |
| 30 | MP0005000_abnormal_immune_tolerance | 2.45193822 |
| 31 | MP0001756_abnormal_urination | 2.43255728 |
| 32 | MP0005464_abnormal_platelet_physiology | 2.36748074 |
| 33 | MP0001800_abnormal_humoral_immune | 2.33605624 |
| 34 | MP0002723_abnormal_immune_serum | 2.28133374 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 2.25333141 |
| 36 | MP0002452_abnormal_antigen_presenting | 2.25013984 |
| 37 | MP0002420_abnormal_adaptive_immunity | 2.21486031 |
| 38 | MP0001819_abnormal_immune_cell | 2.19842445 |
| 39 | MP0001533_abnormal_skeleton_physiology | 2.15692165 |
| 40 | MP0002132_abnormal_respiratory_system | 2.15315653 |
| 41 | MP0003828_pulmonary_edema | 2.13249656 |
| 42 | MP0000538_abnormal_urinary_bladder | 2.11809307 |
| 43 | MP0005671_abnormal_response_to | 2.11399277 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 2.04764514 |
| 45 | MP0009278_abnormal_bone_marrow | 2.03749564 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.96539594 |
| 47 | MP0000462_abnormal_digestive_system | 1.91729665 |
| 48 | MP0002405_respiratory_system_inflammati | 1.82205237 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.75908717 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.75712715 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.74859066 |
| 52 | MP0004947_skin_inflammation | 1.74765499 |
| 53 | MP0009840_abnormal_foam_cell | 1.71652100 |
| 54 | MP0002136_abnormal_kidney_physiology | 1.70751983 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.66780476 |
| 56 | MP0003075_altered_response_to | 1.64582574 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 1.64389150 |
| 58 | MP0003878_abnormal_ear_physiology | 1.64389150 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.63887419 |
| 60 | MP0005083_abnormal_biliary_tract | 1.63532505 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.59697902 |
| 62 | MP0000858_altered_metastatic_potential | 1.59665021 |
| 63 | MP0001851_eye_inflammation | 1.59355043 |
| 64 | MP0004883_abnormal_blood_vessel | 1.56989441 |
| 65 | MP0000716_abnormal_immune_system | 1.55898709 |
| 66 | MP0008469_abnormal_protein_level | 1.55224039 |
| 67 | MP0002398_abnormal_bone_marrow | 1.54013344 |
| 68 | MP0005164_abnormal_response_to | 1.52545841 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.51755383 |
| 70 | MP0009764_decreased_sensitivity_to | 1.51295693 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.50750955 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 1.49649647 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.43119921 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.43119921 |
| 75 | MP0000343_altered_response_to | 1.42238182 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.39789327 |
| 77 | MP0004510_myositis | 1.38889144 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.37617744 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.34517144 |
| 80 | MP0008961_abnormal_basal_metabolism | 1.31720477 |
| 81 | MP0002822_catalepsy | 1.29035141 |
| 82 | MP0002722_abnormal_immune_system | 1.27603700 |
| 83 | MP0005166_decreased_susceptibility_to | 1.27238438 |
| 84 | MP0000689_abnormal_spleen_morphology | 1.26994822 |
| 85 | MP0002429_abnormal_blood_cell | 1.26244264 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.24041065 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 1.22257976 |
| 88 | MP0002735_abnormal_chemical_nociception | 1.21892924 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19267541 |
| 90 | MP0002876_abnormal_thyroid_physiology | 1.18304616 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 1.13242338 |
| 92 | MP0003186_abnormal_redox_activity | 1.12874330 |
| 93 | MP0001664_abnormal_digestion | 1.11689155 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 1.11404197 |
| 95 | MP0002396_abnormal_hematopoietic_system | 1.11118573 |
| 96 | MP0005058_abnormal_lysosome_morphology | 1.10810924 |
| 97 | MP0001853_heart_inflammation | 1.09583517 |
| 98 | MP0005381_digestive/alimentary_phenotyp | 1.08767520 |
| 99 | MP0005310_abnormal_salivary_gland | 1.07585581 |
| 100 | MP0005220_abnormal_exocrine_pancreas | 1.07410508 |
| 101 | MP0000230_abnormal_systemic_arterial | 1.07103498 |
| 102 | MP0009379_abnormal_foot_pigmentation | 1.06183521 |
| 103 | MP0004381_abnormal_hair_follicle | 1.06160373 |
| 104 | MP0005408_hypopigmentation | 1.06011870 |
| 105 | MP0008872_abnormal_physiological_respon | 1.04684521 |
| 106 | MP0002928_abnormal_bile_duct | 1.04045611 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 1.03680408 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 1.03248206 |
| 109 | MP0001663_abnormal_digestive_system | 1.03100566 |
| 110 | MP0003566_abnormal_cell_adhesion | 1.01704314 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 1.01278619 |
| 112 | MP0001764_abnormal_homeostasis | 1.00666634 |
| 113 | MP0005023_abnormal_wound_healing | 1.00452435 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.98522533 |
| 115 | MP0004147_increased_porphyrin_level | 0.97853286 |
| 116 | MP0003191_abnormal_cellular_cholesterol | 0.97616680 |
| 117 | MP0003866_abnormal_defecation | 0.97248540 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.96955547 |
| 119 | MP0000678_abnormal_parathyroid_gland | 0.95543282 |
| 120 | MP0004270_analgesia | 0.95470261 |
| 121 | MP0000490_abnormal_crypts_of | 0.95389320 |
| 122 | MP0005535_abnormal_body_temperature | 0.94528484 |
| 123 | MP0000703_abnormal_thymus_morphology | 0.94500775 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.94080644 |
| 125 | MP0009763_increased_sensitivity_to | 0.93586198 |
| 126 | MP0004858_abnormal_nervous_system | 0.91802732 |
| 127 | MP0004885_abnormal_endolymph | 0.91585082 |
| 128 | MP0003879_abnormal_hair_cell | 0.90304952 |
| 129 | MP0000609_abnormal_liver_physiology | 0.89947736 |
| 130 | MP0003448_altered_tumor_morphology | 0.89162886 |
| 131 | MP0005390_skeleton_phenotype | 0.88495820 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.86826615 |
| 133 | MP0002163_abnormal_gland_morphology | 0.84697825 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.84114275 |
| 135 | MP0003656_abnormal_erythrocyte_physiolo | 0.83833402 |
| 136 | MP0005451_abnormal_body_composition | 0.82991403 |
| 137 | MP0003953_abnormal_hormone_level | 0.82798399 |
| 138 | MP0001485_abnormal_pinna_reflex | 0.82422365 |
| 139 | MP0009642_abnormal_blood_homeostasis | 0.81408600 |
| 140 | MP0002332_abnormal_exercise_endurance | 0.80949968 |
| 141 | MP0001270_distended_abdomen | 0.79485511 |
| 142 | MP0006276_abnormal_autonomic_nervous | 0.78732168 |
| 143 | MP0008874_decreased_physiological_sensi | 0.77430834 |
| 144 | MP0003690_abnormal_glial_cell | 0.74467594 |
| 145 | MP0003315_abnormal_perineum_morphology | 0.74044170 |
| 146 | MP0003091_abnormal_cell_migration | 0.73351844 |
| 147 | MP0003868_abnormal_feces_composition | 0.72836510 |
| 148 | MP0000249_abnormal_blood_vessel | 0.72130650 |
| 149 | MP0002693_abnormal_pancreas_physiology | 0.71938883 |
| 150 | MP0002089_abnormal_postnatal_growth/wei | 0.71933917 |
| 151 | MP0003795_abnormal_bone_structure | 0.70634294 |
| 152 | MP0002736_abnormal_nociception_after | 0.69438624 |
| 153 | MP0002734_abnormal_mechanical_nocicepti | 0.68092081 |
| 154 | MP0003045_fibrosis | 0.67769581 |
| 155 | MP0009053_abnormal_anal_canal | 0.66844170 |
| 156 | MP0001873_stomach_inflammation | 0.66240982 |
| 157 | MP0008004_abnormal_stomach_pH | 0.64759424 |
| 158 | MP0002733_abnormal_thermal_nociception | 0.63775247 |
| 159 | MP0003638_abnormal_response/metabolism_ | 0.62979898 |
| 160 | MP0003959_abnormal_lean_body | 0.59807544 |
| 161 | MP0005448_abnormal_energy_balance | 0.59273980 |
| 162 | MP0005376_homeostasis/metabolism_phenot | 0.58777362 |
| 163 | MP0009765_abnormal_xenobiotic_induced | 0.58210257 |
| 164 | MP0004808_abnormal_hematopoietic_stem | 0.57717379 |
| 165 | MP0002796_impaired_skin_barrier | 0.55974423 |
| 166 | MP0001968_abnormal_touch/_nociception | 0.55508236 |
| 167 | MP0001958_emphysema | 0.54851579 |
| 168 | MP0002933_joint_inflammation | 0.54803652 |
| 169 | MP0000013_abnormal_adipose_tissue | 0.54483636 |
| 170 | MP0002135_abnormal_kidney_morphology | 0.54094297 |
| 171 | MP0000477_abnormal_intestine_morphology | 0.52614104 |
| 172 | MP0002168_other_aberrant_phenotype | 0.52106694 |
| 173 | MP0005395_other_phenotype | 0.51170102 |
| 174 | MP0001986_abnormal_taste_sensitivity | 0.50614495 |
| 175 | MP0009697_abnormal_copulation | 0.48246269 |
| 176 | MP0006035_abnormal_mitochondrial_morpho | 0.48010683 |
| 177 | MP0000613_abnormal_salivary_gland | 0.47658810 |
| 178 | MP0000537_abnormal_urethra_morphology | 0.45821719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.58854879 |
| 2 | Abnormality of macrophages (HP:0004311) | 6.07058136 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.01141176 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.84101796 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 5.56735049 |
| 6 | Myositis (HP:0100614) | 5.45413708 |
| 7 | Gout (HP:0001997) | 5.19756203 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 5.17539136 |
| 9 | Orchitis (HP:0100796) | 5.14698326 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.07069382 |
| 11 | Hypokalemic alkalosis (HP:0001949) | 4.86360409 |
| 12 | Metabolic alkalosis (HP:0200114) | 4.82553125 |
| 13 | Hypochromic microcytic anemia (HP:0004840) | 4.79029242 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.77308725 |
| 15 | Stomatitis (HP:0010280) | 4.72654842 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.58579566 |
| 17 | Optic neuritis (HP:0100653) | 4.58579566 |
| 18 | Increased circulating renin level (HP:0000848) | 4.57929897 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.22487501 |
| 20 | Hypomagnesemia (HP:0002917) | 4.22405852 |
| 21 | Proximal tubulopathy (HP:0000114) | 4.14927763 |
| 22 | Hyperglycinuria (HP:0003108) | 4.10498167 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 4.10120586 |
| 24 | Obstructive lung disease (HP:0006536) | 4.10120586 |
| 25 | Abnormality of magnesium homeostasis (HP:0004921) | 4.02499387 |
| 26 | Glycosuria (HP:0003076) | 4.02316865 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 4.02316865 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 4.01050402 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.99857881 |
| 30 | Alkalosis (HP:0001948) | 3.99738207 |
| 31 | Abnormal urine output (HP:0012590) | 3.97109095 |
| 32 | Polyuria (HP:0000103) | 3.94820941 |
| 33 | Abnormality of purine metabolism (HP:0004352) | 3.90511974 |
| 34 | Hyperphosphaturia (HP:0003109) | 3.83603954 |
| 35 | Increased purine levels (HP:0004368) | 3.79863142 |
| 36 | Hyperuricemia (HP:0002149) | 3.79863142 |
| 37 | Urticaria (HP:0001025) | 3.78775794 |
| 38 | Abnormality of renal excretion (HP:0011036) | 3.77648919 |
| 39 | Abnormality of renin-angiotensin system (HP:0000847) | 3.72622048 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.66550070 |
| 41 | Hypochromic anemia (HP:0001931) | 3.63976399 |
| 42 | Ketoacidosis (HP:0001993) | 3.63153497 |
| 43 | Increased IgE level (HP:0003212) | 3.54510060 |
| 44 | Recurrent skin infections (HP:0001581) | 3.54162832 |
| 45 | Ileus (HP:0002595) | 3.52423006 |
| 46 | Amyloidosis (HP:0011034) | 3.51667598 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 3.45899618 |
| 48 | Petechiae (HP:0000967) | 3.44819940 |
| 49 | Hyperaldosteronism (HP:0000859) | 3.44295816 |
| 50 | Gingivitis (HP:0000230) | 3.42622979 |
| 51 | Prolonged bleeding time (HP:0003010) | 3.39623337 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 3.39109670 |
| 53 | Recurrent fungal infections (HP:0002841) | 3.38288829 |
| 54 | Meningitis (HP:0001287) | 3.37117692 |
| 55 | Abnormal urine phosphate concentration (HP:0012599) | 3.36723179 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25935006 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 3.25748985 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.25748985 |
| 59 | Episodic fever (HP:0001954) | 3.21522908 |
| 60 | Renal salt wasting (HP:0000127) | 3.15026602 |
| 61 | Keratoconjunctivitis (HP:0001096) | 3.13991399 |
| 62 | Encephalitis (HP:0002383) | 3.11926181 |
| 63 | Spontaneous hematomas (HP:0007420) | 3.11881754 |
| 64 | Pustule (HP:0200039) | 3.09657292 |
| 65 | Malnutrition (HP:0004395) | 3.09467831 |
| 66 | Ketosis (HP:0001946) | 3.08871288 |
| 67 | Hypokalemia (HP:0002900) | 3.06995823 |
| 68 | Hydroxyprolinuria (HP:0003080) | 3.06707585 |
| 69 | Abnormality of proline metabolism (HP:0010907) | 3.06707585 |
| 70 | Hypoglycemic coma (HP:0001325) | 3.05821700 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.01834316 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.01834316 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 3.01834316 |
| 74 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98847801 |
| 75 | Vasculitis (HP:0002633) | 2.94082667 |
| 76 | Gingival bleeding (HP:0000225) | 2.93957478 |
| 77 | Polydipsia (HP:0001959) | 2.92569074 |
| 78 | Abnormal drinking behavior (HP:0030082) | 2.92569074 |
| 79 | Acute encephalopathy (HP:0006846) | 2.90246746 |
| 80 | Anorexia (HP:0002039) | 2.88582479 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.85769436 |
| 82 | Cellulitis (HP:0100658) | 2.82902890 |
| 83 | Purpura (HP:0000979) | 2.82158536 |
| 84 | Late onset (HP:0003584) | 2.78290722 |
| 85 | Epistaxis (HP:0000421) | 2.77837700 |
| 86 | Abnormal tarsal ossification (HP:0008369) | 2.77160120 |
| 87 | Hypercalciuria (HP:0002150) | 2.75522502 |
| 88 | Tetany (HP:0001281) | 2.74282924 |
| 89 | Hypophosphatemia (HP:0002148) | 2.72969721 |
| 90 | Hyperglycinemia (HP:0002154) | 2.69903668 |
| 91 | Nephrolithiasis (HP:0000787) | 2.69033205 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.67368053 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.67368053 |
| 94 | Conjugated hyperbilirubinemia (HP:0002908) | 2.64272870 |
| 95 | Loss of speech (HP:0002371) | 2.63002700 |
| 96 | Microcytic anemia (HP:0001935) | 2.60848679 |
| 97 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60650608 |
| 98 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60650608 |
| 99 | Metabolic acidosis (HP:0001942) | 2.58738543 |
| 100 | Hyperammonemia (HP:0001987) | 2.58401791 |
| 101 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.58112744 |
| 102 | Pulmonary infiltrates (HP:0002113) | 2.56737153 |
| 103 | Increased serum ferritin (HP:0003281) | 2.56629433 |
| 104 | Increased IgM level (HP:0003496) | 2.56433496 |
| 105 | Vacuolated lymphocytes (HP:0001922) | 2.56063112 |
| 106 | Chest pain (HP:0100749) | 2.55291493 |
| 107 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.54361340 |
| 108 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.53712078 |
| 109 | Lethargy (HP:0001254) | 2.53568730 |
| 110 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.50708677 |
| 111 | Xanthomatosis (HP:0000991) | 2.50546948 |
| 112 | Renal tubular acidosis (HP:0001947) | 2.50180197 |
| 113 | Abnormal platelet volume (HP:0011876) | 2.49917420 |
| 114 | Peritonitis (HP:0002586) | 2.48196578 |
| 115 | Delayed epiphyseal ossification (HP:0002663) | 2.47741739 |
| 116 | Osteomyelitis (HP:0002754) | 2.43271170 |
| 117 | Hepatic necrosis (HP:0002605) | 2.42509146 |
| 118 | Dehydration (HP:0001944) | 2.42449496 |
| 119 | Hemoptysis (HP:0002105) | 2.42069311 |
| 120 | Decreased circulating renin level (HP:0003351) | 2.41758112 |
| 121 | Abnormality of renal resorption (HP:0011038) | 2.39649776 |
| 122 | Vomiting (HP:0002013) | 2.39424855 |
| 123 | Abnormality of potassium homeostasis (HP:0011042) | 2.39065661 |
| 124 | Symptomatic seizures (HP:0011145) | 2.38678068 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 2.37948905 |
| 126 | Widely patent fontanelles and sutures (HP:0004492) | 2.35721227 |
| 127 | Potter facies (HP:0002009) | 2.34458022 |
| 128 | Facial shape deformation (HP:0011334) | 2.34458022 |
| 129 | Arterial thrombosis (HP:0004420) | 2.33273640 |
| 130 | Intrahepatic cholestasis (HP:0001406) | 2.32159960 |
| 131 | Inflammation of the large intestine (HP:0002037) | 2.31559306 |
| 132 | Premature loss of primary teeth (HP:0006323) | 2.30455290 |
| 133 | Abnormal hemoglobin (HP:0011902) | 2.30121162 |
| 134 | Rickets (HP:0002748) | 2.27738331 |
| 135 | Gastrointestinal inflammation (HP:0004386) | 2.25945795 |
| 136 | Gangrene (HP:0100758) | 2.25097041 |
| 137 | Cerebral edema (HP:0002181) | 2.24251179 |
| 138 | Abnormality of the pericardium (HP:0001697) | 2.23860783 |
| 139 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.23178957 |
| 140 | Acute necrotizing encephalopathy (HP:0006965) | 2.21994386 |
| 141 | Pulmonary embolism (HP:0002204) | 2.21986330 |
| 142 | Increased cerebral lipofuscin (HP:0011813) | 2.21272305 |
| 143 | Skin ulcer (HP:0200042) | 2.20848989 |
| 144 | Toxemia of pregnancy (HP:0100603) | 2.20726232 |
| 145 | Adrenal overactivity (HP:0002717) | 2.20092442 |
| 146 | Polycythemia (HP:0001901) | 2.20030442 |
| 147 | Hypoglycemic seizures (HP:0002173) | 2.18684824 |
| 148 | Hypergammaglobulinemia (HP:0010702) | 2.15880714 |
| 149 | Leukocytosis (HP:0001974) | 2.15227487 |
| 150 | Renal tubular dysfunction (HP:0000124) | 2.14636239 |
| 151 | Mitochondrial inheritance (HP:0001427) | 2.14239435 |
| 152 | Irritability (HP:0000737) | 2.13973098 |
| 153 | Granulocytopenia (HP:0001913) | 2.13144630 |
| 154 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.12994294 |
| 155 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.12412216 |
| 156 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11415621 |
| 157 | Methylmalonic aciduria (HP:0012120) | 2.08177074 |
| 158 | Sepsis (HP:0100806) | 2.07814084 |
| 159 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07461878 |
| 160 | Thin bony cortex (HP:0002753) | 2.05956965 |
| 161 | Glomerulopathy (HP:0100820) | 2.05166251 |
| 162 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.02970577 |
| 163 | Systemic lupus erythematosus (HP:0002725) | 2.01364636 |
| 164 | Cheilitis (HP:0100825) | 2.00307116 |
| 165 | Hepatocellular necrosis (HP:0001404) | 2.00286400 |
| 166 | Flat acetabular roof (HP:0003180) | 2.00127632 |
| 167 | Acne (HP:0001061) | 1.99686064 |
| 168 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98495567 |
| 169 | Muscle fiber splitting (HP:0003555) | 1.98296109 |
| 170 | Vascular calcification (HP:0004934) | 1.97455704 |
| 171 | Abnormality of carpal bone ossification (HP:0006257) | 1.97308254 |
| 172 | Abdominal distention (HP:0003270) | 1.96829834 |
| 173 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93994492 |
| 174 | Hypotension (HP:0002615) | 1.93585229 |
| 175 | Abnormality of the pleura (HP:0002103) | 1.93022638 |
| 176 | Abnormality of T cell physiology (HP:0011840) | 1.92804595 |
| 177 | Progressive neurologic deterioration (HP:0002344) | 1.92075808 |
| 178 | Skin rash (HP:0000988) | 1.91233080 |
| 179 | Hypobetalipoproteinemia (HP:0003563) | 1.90836947 |
| 180 | Enlarged kidneys (HP:0000105) | 1.90818903 |
| 181 | Abnormality of T cells (HP:0002843) | 1.89052161 |
| 182 | Recurrent viral infections (HP:0004429) | 1.88946497 |
| 183 | Pheochromocytoma (HP:0002666) | 1.88026271 |
| 184 | Hyperparathyroidism (HP:0000843) | 1.87762202 |
| 185 | Disinhibition (HP:0000734) | 1.86749927 |
| 186 | Abnormality of T cell number (HP:0011839) | 1.86557610 |
| 187 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85960345 |
| 188 | Impaired platelet aggregation (HP:0003540) | 1.85812526 |
| 189 | Abnormal platelet function (HP:0011869) | 1.85812526 |
| 190 | Menorrhagia (HP:0000132) | 1.83938616 |
| 191 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82527204 |
| 192 | Hypermelanotic macule (HP:0001034) | 1.82437219 |
| 193 | Lymphopenia (HP:0001888) | 1.78980265 |
| 194 | Axonal loss (HP:0003447) | 1.78681502 |
| 195 | T lymphocytopenia (HP:0005403) | 1.78636119 |
| 196 | Splenomegaly (HP:0001744) | 1.78533777 |
| 197 | Dysostosis multiplex (HP:0000943) | 1.77774074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.89543473 |
| 2 | LMTK2 | 5.33151948 |
| 3 | RIPK4 | 4.66443221 |
| 4 | TAOK3 | 4.56122167 |
| 5 | WNK3 | 4.49820681 |
| 6 | OXSR1 | 3.90538423 |
| 7 | MAP2K3 | 3.43914447 |
| 8 | IRAK4 | 3.38861741 |
| 9 | FRK | 3.08085312 |
| 10 | BLK | 2.86089450 |
| 11 | STK39 | 2.84733881 |
| 12 | MAP4K1 | 2.77390448 |
| 13 | MAP3K2 | 2.68560264 |
| 14 | CSK | 2.56573377 |
| 15 | TYK2 | 2.47190284 |
| 16 | SIK3 | 2.46509246 |
| 17 | NME1 | 2.37128934 |
| 18 | PRKG2 | 2.32949282 |
| 19 | BCKDK | 2.18446768 |
| 20 | TNK2 | 2.17996832 |
| 21 | ZAP70 | 2.14987681 |
| 22 | PRPF4B | 2.02555620 |
| 23 | FES | 2.01561932 |
| 24 | EPHB2 | 2.01026332 |
| 25 | INSRR | 1.95843199 |
| 26 | FGR | 1.82984201 |
| 27 | MST1R | 1.82695412 |
| 28 | MAPK15 | 1.81873842 |
| 29 | STK38L | 1.75419965 |
| 30 | MAP2K2 | 1.71942527 |
| 31 | HCK | 1.62660852 |
| 32 | ERN1 | 1.50931108 |
| 33 | MST4 | 1.50154019 |
| 34 | BTK | 1.47913386 |
| 35 | TAOK2 | 1.47151964 |
| 36 | MAP3K13 | 1.46628531 |
| 37 | TESK2 | 1.45039138 |
| 38 | TBK1 | 1.43484835 |
| 39 | JAK3 | 1.34763545 |
| 40 | SGK223 | 1.33522454 |
| 41 | SGK494 | 1.33522454 |
| 42 | STK10 | 1.31670049 |
| 43 | WNK1 | 1.27514890 |
| 44 | CSF1R | 1.24585860 |
| 45 | SYK | 1.21116771 |
| 46 | FER | 1.20402884 |
| 47 | PTK2 | 1.19084686 |
| 48 | LYN | 1.15959479 |
| 49 | YES1 | 1.15083344 |
| 50 | JAK2 | 1.14105651 |
| 51 | MAP3K14 | 1.13498254 |
| 52 | RIPK1 | 1.12211234 |
| 53 | PAK4 | 1.11971706 |
| 54 | IRAK3 | 1.11591085 |
| 55 | IKBKE | 1.08160532 |
| 56 | GRK5 | 1.07709295 |
| 57 | NEK1 | 1.07217334 |
| 58 | TESK1 | 1.06478583 |
| 59 | TGFBR2 | 1.05621033 |
| 60 | MAP3K6 | 1.04960091 |
| 61 | FGFR4 | 1.03691096 |
| 62 | EPHA2 | 1.02570719 |
| 63 | ARAF | 1.01389710 |
| 64 | TXK | 0.99472550 |
| 65 | MAP3K3 | 0.97937136 |
| 66 | SCYL2 | 0.96516599 |
| 67 | PRKD2 | 0.95765129 |
| 68 | LIMK1 | 0.94235344 |
| 69 | GRK6 | 0.93945712 |
| 70 | MAP3K12 | 0.93325593 |
| 71 | SIK1 | 0.92661841 |
| 72 | MAP2K1 | 0.89498625 |
| 73 | LCK | 0.89052612 |
| 74 | PTK6 | 0.88697412 |
| 75 | MARK3 | 0.88310128 |
| 76 | KSR2 | 0.88239041 |
| 77 | IKBKB | 0.84673728 |
| 78 | SMG1 | 0.83030984 |
| 79 | PDK4 | 0.81827032 |
| 80 | PDK3 | 0.81827032 |
| 81 | BMPR2 | 0.81649678 |
| 82 | KSR1 | 0.81535732 |
| 83 | PRKCI | 0.81426666 |
| 84 | NTRK1 | 0.81070508 |
| 85 | IRAK2 | 0.80223229 |
| 86 | PDK1 | 0.78487638 |
| 87 | PTK2B | 0.77663389 |
| 88 | PDK2 | 0.77528540 |
| 89 | PASK | 0.76895523 |
| 90 | JAK1 | 0.76847818 |
| 91 | MOS | 0.74912099 |
| 92 | CDK19 | 0.74567050 |
| 93 | BMX | 0.72864662 |
| 94 | MARK2 | 0.72555925 |
| 95 | EPHA3 | 0.72203718 |
| 96 | RAF1 | 0.71801159 |
| 97 | MYLK | 0.71701383 |
| 98 | AKT3 | 0.69571594 |
| 99 | PRKD3 | 0.69389933 |
| 100 | NME2 | 0.68592643 |
| 101 | NTRK3 | 0.65944405 |
| 102 | MAP3K8 | 0.64849257 |
| 103 | MAP3K5 | 0.64366045 |
| 104 | BRAF | 0.63550193 |
| 105 | MAPKAPK2 | 0.63468198 |
| 106 | MAP2K6 | 0.62064832 |
| 107 | FYN | 0.61603013 |
| 108 | IRAK1 | 0.61300043 |
| 109 | PIK3CA | 0.59402212 |
| 110 | MAPKAPK3 | 0.58716588 |
| 111 | TEC | 0.56902159 |
| 112 | LATS2 | 0.55963613 |
| 113 | SGK2 | 0.55480743 |
| 114 | ITK | 0.54199686 |
| 115 | MINK1 | 0.53796726 |
| 116 | SIK2 | 0.52355933 |
| 117 | SGK3 | 0.51934137 |
| 118 | EPHB1 | 0.51488909 |
| 119 | MAP3K1 | 0.51165218 |
| 120 | MET | 0.48428488 |
| 121 | MAP3K9 | 0.48249921 |
| 122 | MAP3K11 | 0.47877895 |
| 123 | TIE1 | 0.47580283 |
| 124 | PAK3 | 0.47003616 |
| 125 | KIT | 0.46275859 |
| 126 | MAPK12 | 0.45340914 |
| 127 | GSK3A | 0.44218729 |
| 128 | PRKAA1 | 0.43830422 |
| 129 | ABL2 | 0.43521444 |
| 130 | PIM2 | 0.43265205 |
| 131 | STK24 | 0.41786383 |
| 132 | PRKCQ | 0.41699358 |
| 133 | NEK9 | 0.41085995 |
| 134 | HIPK2 | 0.40110328 |
| 135 | MAPK7 | 0.39737137 |
| 136 | ERBB2 | 0.39581167 |
| 137 | RET | 0.38188880 |
| 138 | PDPK1 | 0.38147221 |
| 139 | CAMK2G | 0.37798585 |
| 140 | PIK3CG | 0.37792285 |
| 141 | ADRBK1 | 0.37508801 |
| 142 | LRRK2 | 0.37424379 |
| 143 | PRKACG | 0.37284504 |
| 144 | MAPK11 | 0.36894327 |
| 145 | STK38 | 0.35370107 |
| 146 | ERBB4 | 0.35195409 |
| 147 | PRKCD | 0.35024164 |
| 148 | TAOK1 | 0.34123731 |
| 149 | RPS6KA2 | 0.34054138 |
| 150 | PRKCA | 0.32035709 |
| 151 | GRK7 | 0.30733414 |
| 152 | CAMK2D | 0.30603833 |
| 153 | STK11 | 0.30460954 |
| 154 | PRKAA2 | 0.28814524 |
| 155 | MATK | 0.27801142 |
| 156 | MAP2K4 | 0.27503766 |
| 157 | PRKCE | 0.27230284 |
| 158 | PRKACA | 0.26908255 |
| 159 | CDC42BPA | 0.25065937 |
| 160 | BRSK2 | 0.23792391 |
| 161 | EIF2AK1 | 0.23452627 |
| 162 | DAPK2 | 0.22008617 |
| 163 | PRKCZ | 0.21329022 |
| 164 | TRIB3 | 0.20588721 |
| 165 | ROCK1 | 0.18992711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.22367153 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.20878744 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.08825133 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90314412 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89513982 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.85940138 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.83577962 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.81588456 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.52010897 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49285756 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.41894579 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39826588 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.32080585 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30081326 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 2.30004705 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.25808513 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.16597847 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.14836893 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.14762600 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.13170907 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 2.12130583 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.03370664 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01141766 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.00332798 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.99235739 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.98983623 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.98831628 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.95542564 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.92924181 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.90236839 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87067421 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86455904 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.84718517 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.83639534 |
| 35 | Mineral absorption_Homo sapiens_hsa04978 | 1.80715729 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.70095430 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.68815779 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.68780553 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66102827 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64957049 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64778852 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.62410664 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.59057205 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58957133 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58226028 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.55689454 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.52268073 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50953795 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47883220 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.47878392 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47562058 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.47147841 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45924675 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45386939 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44955015 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44762130 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44563880 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 1.42245211 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.42110893 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41578085 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.41284765 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38631675 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36248125 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 1.35962820 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34427068 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33628807 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.33352002 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32528084 |
| 69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.29610548 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27019014 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26948588 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.26908267 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26132306 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26073067 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25703342 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25415058 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25224773 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20280284 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.20078702 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20035541 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19481773 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19376315 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18247981 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16794787 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 1.16333678 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15253632 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14672744 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14621894 |
| 89 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.14279377 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13856251 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12765004 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12059569 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09867256 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07886711 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.07842485 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07622683 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06417659 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06277493 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 1.05971899 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 1.04142883 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03009991 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02606495 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 1.02427422 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02365578 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00590037 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00117370 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.99984674 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.99933688 |
| 109 | Protein export_Homo sapiens_hsa03060 | 0.99859860 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98118406 |
| 111 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95637476 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95294979 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94791081 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93126477 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.92369426 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90016924 |
| 117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89731537 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88136919 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86307383 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84231484 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79119456 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78560547 |
| 123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77413191 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75422696 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73909315 |
| 126 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.71957182 |
| 127 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71914991 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70923356 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69467027 |
| 130 | Asthma_Homo sapiens_hsa05310 | 0.68526623 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65248850 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63792137 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63112543 |
| 134 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62880400 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62071120 |
| 136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62001305 |
| 137 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61351003 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61263738 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57892554 |
| 140 | ABC transporters_Homo sapiens_hsa02010 | 0.57135841 |
| 141 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56921928 |
| 142 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56221653 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55594774 |
| 144 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55204311 |
| 145 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54391551 |
| 146 | Insulin secretion_Homo sapiens_hsa04911 | 0.52563261 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51570871 |
| 148 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49659396 |
| 149 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49608100 |
| 150 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48594279 |
| 151 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47984364 |
| 152 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47728955 |
| 153 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45920648 |
| 154 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45655946 |
| 155 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45562052 |
| 156 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44947987 |
| 157 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44842592 |
| 158 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44563846 |
| 159 | Lysine degradation_Homo sapiens_hsa00310 | 0.42941476 |
| 160 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42758140 |
| 161 | Insulin resistance_Homo sapiens_hsa04931 | 0.41125426 |
| 162 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40967307 |
| 163 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38826905 |
| 164 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38277739 |
| 165 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37332870 |
| 166 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35774412 |
| 167 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34672741 |
| 168 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34014608 |
| 169 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34008454 |
| 170 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33992082 |
| 171 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33207600 |
| 172 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32964650 |
| 173 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32638726 |
| 174 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27049295 |
| 175 | Lysosome_Homo sapiens_hsa04142 | 0.24426789 |
| 176 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22084447 |
| 177 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20451521 |
| 178 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19259854 |
| 179 | Bladder cancer_Homo sapiens_hsa05219 | 0.17173332 |
| 180 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15224855 |
| 181 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.14784189 |
| 182 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13167964 |
| 183 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.09739775 |

